Enhanced nitric oxide (NO) generation by stimulated NO synthase (NOS) activity may, through its oxidative metabolism contribute to tissue injury in experimental colitis. In this study the possible amelioration of experimental colitis by NG-nitro-Larginine methyl ester (L-NAME), an inhibitor of NOS activity, was evaluated. Colitis was induced in rats by intracolonic administration of 30 mg trinitrobenzene sulphonic acid (TNB) dissolved in 0.25 ml 50%/o ethanol or by flushing the colon of capsaicin pretreated rats with 2 ml of 50/0 acetic acid. In several experiments, L-NAME 0-1 mg/ml was added to the drinking water at the time of colitis induction with TNB or seven days before acetic acid treatment. Rats were killed at various time intervals after induction of colitis. A 10 cm distal colonic segment was isolated, weighed, lesion area measured, and explants organ cultured for 24 hours for determination of NO generation by the Greiss reaction. The rest of the mucosa was scraped for determination of myeloperoxidase and NOS activities and leukotriene generation. In TNB treated rats mean arterial pressure was also determined up to 72 hours after damage induction, with or without cotreatment with nitroprusside. L-NAME significantly decreased the extent of tissue injury in TNB treated rats. Seven days after TNB treatment lesion area was reduced by 55°/0, colonic weight by 37%, and myeloperoxidase and NOS activity by 590/o and 42%, respectively. Acetic acid induced colitis in capsaicin pretreated rats was also significantly decreased by L-NAME. Twenty four hours after acetic acid treatment lesion area was reduced by 61%/ colonic weight by 21%, and NOS activity by 39%. Mean (SEM) arterial blood pressure in TNB+L-NAME treated rats was 37.6 (8.1) mm Hg higher than in TNB treated rats, an effect that was only partially abolished by nitroprusside. These results show that inhibition of NO synthesis by an L-arginine analogue significantly ameliorates the extent of tissue injury in two models of experimental colitis, an effect that is not due only to its vasoconstrictor properties. Modulation of NO generation may be a novel therapeutic approach in inflammatory bowel disease. (Gut 1995; 37: 247-255) 
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Nitric oxide (NO) has been implicated in diverse biological functions, mediation of macrophage function being one of them.1 Basal NO synthase (NOS) activity in macrophages is negligible but, once stimulated by bacterial products or cytokines, NO generation is significantly increased.2 NO generation by activated macrophages has an important role in the defence against infectious agents as well as tumour cells.' 3 When actively produced in large amounts, however, NO may induce tissue injury due to its combination with superoxide anion yielding peroxynitrite. We have shown in rats that intracolonic administration of peroxynitrite induces significant colonic injury. 4 Recently, in patients with inflammatory bowel disease, colonic NO generation5 and NOS activity5 6 were reported to be stimulated.
Moreover, stimulated colonic NOS activity was reported in the rat model of trinitrobenzene sulphonic acid (TNB) induced colitis7 and NO generation was found to be increased in TNB induced ileitis in guinea pigs.8 It is thus suggested that increased NO generation by stimulated NOS activity may contribute to the pathogenesis of experimental colitis and inflammatory bowel disease. Inhibition of NOS activity may, therefore, ameliorate the extent of tissue inflammation and may be used as a novel therapeutic modality in inflammatory bowel disease patients. Analogue of Larginine such as NG-nitro-L-arginine methyl ester (L-NAME) and NG-monomethyl-L-arginine (L-NMMA) are potent inhibitors of NOS activity and L-NAME was shown to ameliorate the extent of TNB induced ileitis on guinea pigs.8 The mechanism, however, whereby L-NAME induces its effect and, especially, its potent vasoconstricting effects in this setting was not established.
The aim of this study was to further evaluate the possible contribution of NO to the pathogenesis of several models of experimental colitis and to assess their possible amelioration through potent inhibition of NOS activity.
Methods

Materials
L-arginine, L-citrulline, NW-nitro-L-arginine (NNA), L-NAME, L-NMMA, NADPH, calcium ionophore, lipopolysaccharide, dithiothreitol, phenylmethylsulphonyl fluoride, EDTA, and EGTA were purchased from Sigma Chemical, St Louis, MO, USA; Dowex AG5OW-X8 (Na form) 100-200 mesh, and TRIS base (electrophoresis grade) were purchased from Bio-Rad Labs, Richmond, CA, USA; sodium nitrite and sodium nitrate were obtained from Fisher Chemical, Fair Lawn, NJ, USA; opti-fluor was purchased from Packard, the Netherlands; sulphanilamide and N-l-naphthylethylene diamine hydrochloride were purchased from Aldrich Chemical, Milwaukee, MI, USA; TNB was purchased from Eastman Kodak, Rochester, NY, USA; rat recombinant interferon y (IFN y) was purchased from Gibco BRL, Gaithersburg, MD, USA; nitroprusside was purchased from Hoffman-La Roche, Basle, Switzerland; 3H-citrulline, leukotriene B4 (LTB4), leukotriene C4 (LTC4), radioimmunoassay, were purchased from Amersham, Bucks, UK. 24 hours after recovery by use of P23 Statham-Gould transducers (Gould, Oxnard, CA, USA) and recorded on Gould physiograph (model 13-34615-52) after 10-20 minutes of equilibration while rats were moving freely in their cages. Mean arterial pressure was measured before, 24, 48, and 72 hours after TNB treatment and during L-NAME administration to the drinking water. In another group of rats after the basal mean arterial pressure measurement, under ether anaesthesia, an osmotic minipump (Alzet, Palo Alta, CA, USA) was implanted intraperitoneally delivering nitroprusside, 0.42 ,ug/min. Acetic acid induced colitis Acetic acid colitis was induced in control rats and also two weeks after completion of capsaicin treatment in which rats were treated subcutaneously with capsaicin in increasing doses (20, 30 , and 50 mg/kg) on three consecutive days in a regimen shown to deplete neuropeptides in primary afferent neurons.12
In several experiments L-NAME 0.1 mg/ml was added to the drinking water seven days before, or at the time of colitis induction. Under light ether anaesthesia a midline abdominal incision was made and the junction of the caecum and ascending colon identified. Two ml of 5% acetic acid were injected into the lumen of the colon at its proximal part through a 25 gauge needle, followed by 3 ml of air, which cleared most of the acetic acid from the colon. The midline incision was closed. Twenty four hours later the rats were killed and their colons removed and handled, as with the TNB model.
Determination of mucosal damage
Mucosal damage was measured macroscopically and expressed in mm2/rat. All measurements of damage were performed by two blinded observers using a stereomicroscope. The interobserver variability between the two observers was 7%.
Organ culture Colonic explants were kept in NaCl 0. 15 Enzymatic reactions were terminated by addition of 2.0 ml of ice cold 'stop buffer': twenty mM sodium acetate, pH 5.5, 1 mM Lcitrulline, 2 mM EDTA, and 0'2 mM EGTA. Citrulline was determined by applying the samples (2.0 ml) prepared as described above, to columns (1 cm diameter) containing 1 ml of Dowex AG5OW[X8, Na form, which had been pre-equilibrated with stop buffer. Columns were eluted with 4X 1P0 ml of water collected into scintillation vials. Opti-fluor (10 ml) was added to each vial and samples were counted in a Packard Tri-Carb liquid scintillation spectrometer. Citrulline was recovered in the first 4.0 ml of the Dowex column eluate to the extent of 96 (2)%. Interassay variation is 1.0 (1.9)% (mean (SEM); n=55).
Determination of myeloperoxidase activity Two hundred mg of colonic mucosal scrapings were homogenised three times for 30 seconds at 4°C with a polytron (Kinematica GmbH, Kriens-Luzern, Switzerland) in 1.0 ml of ice cold 0.5% hexadecyltrimethylammonium bromide in 50 mM phosphate buffer, pH 6.0. The polytron probe was rinsed twice with 1.0 ml of the buffer and the washings were added to the homogenate. The homogenate was then sonicated for 10 seconds, freeze thawed three times, and centrifuged for 15 minutes at 40 000 g. An aliquot of the supernatant was taken for determination of the enzyme activity, according to Bradley et al. 16 The correlation coefficient based on 10 standard curves is r=0.98. Interassay variation is 0 (1.65)% (mean (SEM); n=57).
Determination of lipoxygenase products One hundred and fifty mg of mucosa were placed in preweighed tubes containing 1-0 ml of phosphate buffer (50 mM, pH 7.4). The mucosa was minced with scissors and centrifuged in an Eppendorf centrifuge for 10 seconds. The pellet was resuspended in 1-0 ml of the above buffer, incubated for one minute in a vortex mixer, indomethacin added, and the tubes centrifuged for 60 seconds. The supematants were kept at -20°C until radioimmunoassays were performed. The capability of the mucosa to generate LTB4 and LTC4 was expressed as ng/g wet tissue weight.
Measurement of LTB4 LTB4 immunoreactivity was determined by a radioimmunoassay kit (Amersham, TRK 940). The assay combines the use of a high specific activity LTB4 tracer, an antiserum specific for LTB4 (cross reactivity 100%), and a leukotriene standard (range 1.6 to 200 pg/tube). The specific binding of tracer is 42.5%, nonspecific binding 2-4%. Measurement of LTC4 LTC4 immunoreactivity was determined by radioimmunoassay. The assay combines the use of a high specific activity LTC4 tritiated tracer with a monoclonal antibody specific for LTC4 and LTC4 standard (8-500 pg/tube). The assay uses highly specific LTC4 antiserum (cross reactivity= 100%) and has low cross reactivity with leukotriene D4 (LTD4) (<5%). The specific binding of tracer is 400/6-45°/O and non-specific binding is 10/o-3%. Fifty per cent B/Bo displacement is obtained with 34 pg/tube, and 80% B/Bo displacement with 9.5 pg/tube of LTC4. The percentage CV for within assay precision ranges from 7.68 (low) to 3.94 (high). The percentage CV for the precision profile of the assay ranges from 1.64 to 3.49 (n=9). The percentage B/Bo for between assay reproducibility ranges from 87 to 5-4 (standard 8-800 pg/tube; n=9).
Morphological studies Sections of colon were obtained from the same areas of the large intestine during necropsy. They were fixed in phosphate buffered formaldehyde, embedded in paraffin wax, and routine 5 Kum sections were prepared. Tissues were routinely stained with haematoxylin and eosin and were evaluated by light microscopy by a pathologist unaware of the experiments being performed. As the histological features of the TNBI0 and acetic acid'7 induced colitis were previously reported by us, only the histology of the new acetic acid augmented colitis in capsaicin pretreated rats is reported in detail.
Statistical analysis Data are expressed as mean (SEM). Statistical (Table I ). The addition of L-NAME to the drinking water induced a significant decrease in the lesion area, but this was noted only three and seven days after damage induction (Table I ). The amelioration of the severity of the inflammatory response in L-NAME treated rats was also reflected by the significant difference in the wet weight of the 10 cm long distal colonic segment in L-NAME and control rats treated with TNB/ethanol (Table I) . At all time intervals colonic myeloperoxidase activity in TNB treated rats was several fold higher than its activity in control rats. In L-NAME+TNB treated rats, myeloperoxidase activity three and seven days after TNB treatment was 40% of its activity in rats treated only with TNB (Fig 1) . In nitroprusside treated rats mucosal myeloperoxidase activity was 0.5 (0.4) u/g, similar to its activity in control rats. In TNB treated rats, one and three days after its administration, mucosal LTB4 generation was significantly increased when compared with its generation in control rats. Mucosal LTC4 generation was significantly increased three and seven days after damage induction. In TNB+L-NAME treated rats mucosal leukotriene generation was lower than in TNB treated rats, but the difference was not statistically significant (Table II) NO. generation by inflamed colonic segments isolated 24 hours after TNB treatment was 11-fold higher than by explants isolated from control rats: 2236 (320) (n= 12) and 204 (36) (n= 19) pumol/g/24 h, respectively.
One, three, and seven days after TNB treatment colonic NOS activity was 4.5-, 22-, and 18-fold higher, respectively, than in control rats. In TNB+L-NAME treated rats, three and seven days after treatment, NOS activity was significantly lower than in TNB treated rats (Fig 2) .
Effect of L-NAME on mean arterial pressure Treatment (days) Figure 1 : Effect of L-NAME on colonic myeloperoxidase activity in TNB treated rats. Colonic myeloperoxidase activity was determined one, three, and seven days after colonic TNB administration to control and L-NAME treated rats, as described in Methods. Results are mean (SEM). *Significantly differentfrom control (p<0-05).
tSignificantly differentfrom TNB treated rats (p<005). Treatment (days) Figure 2 : Effect ofL-NAME on colonic NOS activity in TNB treated rats. Colonic NOS activity was determined one, three, and seven days after colonic TNB administration, as described in Methods. *Significantly different from control (p<005). tSignificantly different from TNB (p<005). treatment did not induce any injury but abolished the protective effect of L-NAME on the extent of tissue injury induced by TNB. L-NAME, by itself, did not induce any macroscopic injury (Table III) .
L-NAME induced in TNB treated rats a significant increase in mean arterial pressure of 37. Effect of L-NAME on acetic acid induced colitis Twenty four hours after administration of acetic acid the colon was haemorrhagic and inflamed. The lesion area, and the wet weight of the 10 cm long distal colonic segment in capsaicin pretreated rats were 3-and 1.5-fold higher, respectively, than in rats treated only with acetic acid (Table IV) . The addition of L-NAME to the drinking water significantly reduced the extent of the augmented acetic acid injury in capsaicin pretreated rats (Table  IV) . Mucosal myeloperoxidase activity in control, acetic acid, and capsaicin+acetic acid treated rats was 09 (0O1) (n=10), 3.5 (0.7) (n=10), and 15.8 (4.4) (n=6) U/g, respectively. L-NAME did not significantly affect mucosal LTB4 and LTC4 generation in control rats. Both in acetic acid and in capsaicin+acetic acid treated rats colonic LTB4 generation was significantly increased when compared with its generation in control rats. The amelioration of the extent of the colonic damage in L-NAME treated rats was accompanied by significant decrease in mucosal LTB4 generation (Fig 4) . Mucosal LTC4 generation was significantly increased only in acetic acid treated rats. Its generation in capsaicin+L-NAME+acetic acid treated rats was significantly lower, however, than in capsaicin+acetic acid treated rats (Fig  4) .
In acetic acid treated rats colonic NOX generation by cultured explants and colonic NOS activity were three-and twofold higher, respectively, than in normal colonic mucosa (Fig 5) . The augmentation of acetic acid induced colitis in capsaicin pretreated rats is accompanied by further increase in NOX generation and NOS activity. On the other hand, both NOx generation and NOS activity were significantly reduced in L-NAME treated rats when compared with their values in acetic acid+capsaicin treated rats. In control rats, the addition of L-NAME to the drinking water generation induced by NNA was more pronounced in explants isolated from normal rats than that seen in explants isolated from rats with experimental colitis (Table V) . Both in normal rats and in rats with experimental colitis, colonic NOS activity was significantly inhibited by NNA and was NADPH dependent (Table VI) . : Effect of L-NAME on colonic leukotriene generation in capsaicin+acetic acid treated rats. Colonic LTB4 and LTC4 generation was determined in rats treated with capsaicin+acetic acid with or without administration ofL-NAME, as described in Methods. A=control; B=L-NAME; C=acetic acid; D=capsaicin+acetic acid;
E=capsaicin+L-NAME+acetic acid. *Significantly differentfrom control (p<005).
tSignificantly differentfrom capsaicin+acetic acid treated rats (p<0 05).
Histological assessment Sections of the large intestine from rats treated with acetic acid showed multiple, full thickness, mucosal ulcerations with moderate oedema of the submucosa, accompanied by moderate inflammatory cell infiltrate (Fig  6(A) ). In rats pretreated with capsaicin before acetic acid treatment, there were widespread ulcerations involving the mucosa and submucosa with extensive haemorrhages, oedema and widespread, acute, inflammatory infiltrate. There was pseudomembrane formation as well as foci of inflammation in the muscularis propria (Fig 6(B) ). Cross sections of colonic segments from rats treated with L-NAME before damage induction by capsaicin and acetic acid disclosed multiple small ulcerations confined to the mucosa, some involving the full thickness of the mucosa with mild to moderate oedema accompanied by mild to moderate inflammatory infiltrate (Fig 6(C) ).
Discussion
In this study inhibition of NOS activity by L-NAME was found to ameliorate the extent and severity of tissue injury in two models of experimental colitis in which colonic NO.
generation and NOS activity were found to be stimulated. These findings support the concentration that NO participates in the pathogenesis of colonic inflammation augmenting and amplifying the extent of tissue injury. Inflamed colonic mucosa is characterised by the abundance of activated inflammatory cells, such as macrophages and neutrophils. The activation of these inflammatory cells is expressed in a variety of ways, including synthesis and release of certain cytokines, inflammatory mediators, such as leukotrienes and platelet activating factor, and the release of reactive oxygen metabolites.18 Recently, these mediators were also shown to induce NO generation by phagocytic leucocytes.2 19 20 Moreover, macrophages and inflammatory neutrophils were shown to contain a calcium and calmodulin independent NOS that is activated by agents, such as lipopolysaccharide and IFN y.' 2 NO is produced from L-arginine by the enzyme, NOS. further suggesting increased NO synthesis in ulcerative colitis.
Within 24 hours, L-NAME significantly increased mean arterial pressure in TNB treated rats, an effect that lasted throughout the 72 hour study period. This is consistent with other longterm studies in one of which hypertension persisted 13 weeks after the four week L-NAME treatment period had finished.26 That acute NO synthesis inhibition causes immediate rise in mean arterial pressure because of widespread vascular constriction is t 20 10 E Ul) 0 z well described.27 This occurs in the renal, hindquarters, carotid and, more pertinent to this study, the mesenteric vascular beds. An acute rise in mean arterial pressure of about 40 mm Hg, similar to that seen in the TNB+L-NAME treated rats herein reported, is associated with a 50% reduction in mesenteric vascular conductance.27 Such a noticeable reduction in mesenteric perfusion may affect the extent of colonic TNB induced damage in several ways: it may reduce the influx of inflammatory cells and mediators; it may reduce the formation of reactive oxygen radicals and; it may reduce the oedema of a given injury.28 The fact that NPS, an NO donor and a direct vasodilator that bypasses NOS pathways, induced complete reversal of the L-NAME protective effects on TNB induced colonic injury while the haemodynamic effects of L-NAME are only partially attenuated, strongly suggests that the L-NAME protective effect cannot be attributed only to its vascular effect.
In this study, L-NAME, the L-arginine analogue that inhibits NOS activity, was found to effectively decrease the extent of colonic injury, both in TNB induced colitis and in the augmented acetic acid induced colitis in capsaicin pretreated rats. After capsaicin depletion of afferent nerve endings the damage induced by acetic acid is augmented. This augmentation was herewith shown to correlate with mucosal NO. generation and stimulated NOS activity, further suggesting the contribution of NO to the pathogenesis of mucosal injury. The protective effect of L-NAME was accompanied by a significant decrease in colonic NOS activity and NO. generation. The amelioration of experimental colitis by L-NAME supports the contention that enhanced NO generation promotes mucosal injury in these two models. In a similar way, L-NAME was shown also, to ameliorate TNB induced ileitis in guinea pigs.8
In all previous studies evaluating the possible modification of gastrointestinal injury by L-NAME, the major haemodynamic changes induced by L-NAME were overlooked. In this study it is clearly shown that reduced mesenteric blood flow and decreased capillary permeability may have a certain role in the remarkable protective effect of L-NAME in TNB induced colitis.
The protective effect provided by L-NAME was accompanied by significant decrease in myeloperoxidase activity and in capsaicin augmented acetic acid induced colitis also in LTB4 and LTC4 generation. Myeloperoxidase activity is expressed in granulocytes and is a sensitive marker of the severity of colonic inflammation.17 LTB4 and LTC4 are potent proinflammatory mediators and the lack of significant decrease in leukotriene generation in the TNB model despite the effective protection provided by L-NAME, shows that their role is probably secondary to that of NO. 
